Download PDF
CC BY 4.0 · Rev Bras Ginecol Obstet 2022; 44(08): 806-818
DOI: 10.1055/s-0042-1756521
Febrasgo Position Statement

Screening, diagnosis and management of hyperthyroidism in pregnancy

Number 8 – Agosto 2022
Carlos Alberto Maganha 
1   Faculdade de Ciências Médicas de São José dos Campos, São José dos Campos, SP, Brazil
,
Rosiane Mattar 
2   Departamento de Obstetrícia, Escola Paulista de Medicina, São Paulo, SP, Brazil
,
Cleo Otaviano Mesa Júnior 
3   Universidade Federal Paraná, Curitiba, PR, Brazil
,
Suemi Marui 
4   Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil
,
Sara Toassa Gomes Solha 
5   Policlínicas Municipal, Sorocaba, SP, Brazil
,
Patrícia de Fátima dos Santos Teixeira 
6   Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
,
Alberto Carlos Moreno Zaconeta 
7   Universidade de Brasília, Brasília, DF, Brazil
,
Renato Teixeira Souza 
8   Universidade Estadual de Campinas, Campinas, SP, Brazil
› Author Affiliations
› Further Information
   Permissions and Reprints

Key points

  • The physiological changes of pregnancy that interfere with the production, release and availability of the active form of hormones interfere with the diagnosis and management of hyperthyroidism during pregnancy.

  • Gestational thyrotoxicosis or transient hyperthyroidism, the most common cause of hyperthyroidism in pregnancy, is related to the increased production of human chorionic gonadotropin (hCG) and may persist until week 18.

  • Untreated hyperthyroidism can have fetal, neonatal, and maternal effects.

  • The obstetrician must be aware of the fetal, neonatal and/or maternal risks caused by the drug treatment of hyperthyroidism during pregnancy.

  • Graves’ disease (GD) is the main pathology etiologically associated with hyperthyroidism in pregnancy.

  • The diagnosis of hyperthyroidism in pregnancy is preferably made by measuring free thyroxine (FT4) and thyroid-stimulating hormone (TSH).

  • The measurement of anti-TSH receptor antibody (TRAb) allows the diagnosis of GD, which is an important cause of hyperthyroidism.

  • Propylthiouracil (PTU) is the first-choice drug for the treatment of hyperthyroidism in pregnancy in the first trimester, while methimazole (MMZ) is used in the second and third trimesters and puerperal period.

  • The use of antithyroid drugs (ATD) is allowed during breastfeeding.

  • Radioactive iodine (131I) should not be used during pregnancy or breastfeeding.

The National Commission Specialized in High Risk Pregnancy of the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Thyroid Department of the Brazilian Society of Endocrinology and Metabology (SBEM) endorse this document. The production of content is based on scientific evidence on the proposed theme and the results presented contribute to clinical practice.




Publication History

Article published online:
08 September 2022

© 2022. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Korevaar TI, Medici M, Visser TJ, Peeters RP. Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol 2017; 13 (10) 610-22
    CrossrefPubMedSearch in Google Scholar
  • 2 Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C. et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 2017; 27 (03) 315-89
    CrossrefPubMedSearch in Google Scholar
  • 3 Morais NS, Assis AS, Corcino CM, Saraiva DA, Berbara T, Ventura CD. et al. Recent recommendations from ATA guidelines to define the upper reference range for serum TSH in the first trimester match reference ranges for pregnant women in Rio de Janeiro. Arch Endocrinol Metab 2018; 62 (04) 386-91
    CrossrefPubMedSearch in Google Scholar
  • 4 Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ. Williams texbook of endocrinology. 14th ed.. Philadelphia: Elsevier; 2020
    CrossrefSearch in Google Scholar
  • 5 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL. et al. 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26 (10) 1343-421
    CrossrefPubMedSearch in Google Scholar
  • 6 Thyroid disease in pregnancy: ACOG Practice Bulletin, Number 223. Obstet Gynecol 2020; 135 (06) e261-74
    CrossrefPubMedSearch in Google Scholar
  • 7 Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol 2013; 1 (03) 238-49
    CrossrefPubMedSearch in Google Scholar
  • 8 Korevaar TIM, Pearce EN. Thyroid disorders during preconception, pregnancy, and the postpartum period. In: Braverman LE, Cooper DS, Kopp PA. editors. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 11th ed.. Philadelphia: Lippincott-Raven; 2021: 922-40
    Search in Google Scholar
  • 9 Iijima S. Pitfalls in the assessment of gestational transient thyrotoxicosis. Gynecol Endocrinol 2020; 36 (08) 662-7
    CrossrefPubMedSearch in Google Scholar
  • 10 Kobaly K, Mandel SJ. Hyperthyroidism and pregnancy. Endocrinol Metab Clin North Am 2019; 48 (03) 533-45
    CrossrefPubMedSearch in Google Scholar
  • 11 Cuff RD. Hyperthyroidism during pregnancy: a clinical approach. Clin Obstet Gynecol 2019; 62 (02) 320-9
    CrossrefPubMedSearch in Google Scholar
  • 12 Barbesino G. Misdiagnosis of Graves’ Disease with apparent severe hyperthyroidism in a patient taking biotin megadoses. Thyroid 2016; 26 (06) 860-3
    CrossrefPubMedSearch in Google Scholar
  • 13 Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994; 84 (06) 946-9
    PubMedSearch in Google Scholar
  • 14 Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006; 107 (2 Pt 1): 337-41
    CrossrefPubMedSearch in Google Scholar
  • 15 Weeke J, Dybkjaer L, Granlie K, Eskjaer Jensen S, Kjaerulff E, Laurberg P. et al. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinol (Copenh) 1982; 101 (04) 531-7
    CrossrefPubMedSearch in Google Scholar
  • 16 Rubin PC. Current concepts: beta-blockers in pregnancy. N Engl J Med 1981; 305 (22) 1323-6
    CrossrefPubMedSearch in Google Scholar
  • 17 Andersen SL, Olsen J, Laurberg P. Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab 2016; 101 (04) 1606-14
    CrossrefPubMedSearch in Google Scholar
  • 18 Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K. Antithyroid drug therapy for Graves’ disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 1986; 315 (01) 24-8
    CrossrefPubMedSearch in Google Scholar
  • 19 De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH. et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012; 97 (08) 2543-65
    CrossrefPubMedSearch in Google Scholar
  • 20 Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J. Management of Graves’ hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009; 160 (01) 1-8
    CrossrefPubMedSearch in Google Scholar
  • 21 Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351 (03) 241-9
    CrossrefPubMedSearch in Google Scholar
  • 22 Lee SY, Pearce EN. Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. Nat Rev Endocrinol 2022; 18 (03) 158-71
    CrossrefPubMedSearch in Google Scholar
  • 23 Paschke R, Niedziela M, Vaidya B, Persani L, Rapoport B, Leclere J. 2012 European Thyroid Association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations. Eur Thyroid J 2012; 1 (03) 142-7
    CrossrefPubMedSearch in Google Scholar
  • 24 Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B. 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children. Eur Thyroid J 2014; 3 (02) 76-94
    CrossrefPubMedSearch in Google Scholar
  • 25 Azizi F, Khoshniat M, Bahrainian M, Hedayati M. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000; 85 (09) 3233-8
    CrossrefPubMedSearch in Google Scholar
  • 26 Gorman CA. Radioiodine and pregnancy. Thyroid 1999; 9 (07) 721-6
    CrossrefPubMedSearch in Google Scholar
  • 27 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE. et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26 (01) 1-133
    Search in Google Scholar
  • 28 Shannon ME, Malecha SE, Cha AJ. Beta blockers and lactation: an update. J Hum Lact 2000; 16 (03) 240-5
    CrossrefPubMedSearch in Google Scholar
  • 29 Stagnaro-Green A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab 2012; 97 (02) 334-42
    CrossrefPubMedSearch in Google Scholar
  • 30 Amino N, Arata N. Thyroid dysfunction following pregnancy and implications for breastfeeding. Best Pract Res Clin Endocrinol Metab 2020; 34 (04) 101438
    CrossrefPubMedSearch in Google Scholar
  • 31 Romney BM, Nickoloff EL, Esser PD, Alderson PO. Radionuclide administration to nursing mothers: mathematically derived guidelines. Radiology 1986; 160 (02) 549-54
    CrossrefPubMedSearch in Google Scholar